Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ionis Pharmaceuticals Inc (NASDAQ: IONS) closed the day trading at $48.00 up 1.46% from the previous closing price of $47.31. In other words, the price has increased by $1.46 from its previous closing price. On the day, 1.6 million shares were traded. IONS stock price reached its highest trading level at $48.24 during the session, while it also had its lowest trading level at $46.84.
Ratios:
For a better understanding of IONS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.28 and its Current Ratio is at 7.37. In the meantime, Its Debt-to-Equity ratio is 6.64 whereas as Long-Term Debt/Eq ratio is at 6.49.
On April 10, 2024, Wolfe Research Upgraded its rating to Outperform which previously was Peer Perform but kept the price unchanged to $58.
BofA Securities Upgraded its Neutral to Buy on January 02, 2024, whereas the target price for the stock was revised from $52 to $62.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 17 ’24 when BERTHELSEN SPENCER R sold 16,000 shares for $40.29 per share. The transaction valued at 644,640 led to the insider holds 147,257 shares of the business.
KLEIN JOSEPH III sold 6,000 shares of IONS for $256,277 on May 03 ’24. The Director now owns 0 shares after completing the transaction at $42.71 per share. On Apr 16 ’24, another insider, Baroldi Joseph, who serves as the EVP, Chief Business Officer of the company, sold 4,006 shares for $41.60 each. As a result, the insider received 166,641 and left with 19,631 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IONS now has a Market Capitalization of 7006319616 and an Enterprise Value of 6770703872. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.02 while its Price-to-Book (P/B) ratio in mrq is 23.61. Its current Enterprise Value per Revenue stands at 8.718 whereas that against EBITDA is -19.093.
Stock Price History:
Over the past 52 weeks, IONS has reached a high of $54.44, while it has fallen to a 52-week low of $35.95. The 50-Day Moving Average of the stock is 15.83%, while the 200-Day Moving Average is calculated to be 5.38%.
Shares Statistics:
Over the past 3-months, IONS traded about 1.25M shares per day on average, while over the past 10 days, IONS traded about 1490430 shares per day. A total of 144.34M shares are outstanding, with a floating share count of 134.19M. Insiders hold about 8.07% of the company’s shares, while institutions hold 96.74% stake in the company. Shares short for IONS as of 1719532800 were 9520997 with a Short Ratio of 7.63, compared to 1717113600 on 8597493. Therefore, it implies a Short% of Shares Outstanding of 9520997 and a Short% of Float of 7.7199996.
